Micro Emerging Active

LTRN FDA Clears Investigational New Drug Application for STAR-001

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
1
Sources
1

Top Movers

TickerSectorChange
LTRN
Healthcare+174.1%

Sentiment Timeline

Sector Performance

Stock Performance

Event Timeline

Mar 27, 2026
Lantern Pharma Stock Falls 10% After FDA Clears Investigational New Drug Application … Neutral

Related Articles

Lantern Pharma Stock Falls 10% After FDA Clears Investigational New Drug Application For STAR-001

Nasdaq · Mar 27, 2026
Mixed

Timeline

First SeenMar 27, 2026
Last UpdatedMar 27, 2026